CP
ELV icon

Corbenic Partners’s Elevance Health ELV Stock Holding History

Corbenic Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11
Closed -$4K – 286
2021
Q3 		$4K Buy
+11
New +$4.18K ﹤0.01% 211
2020
Q1 		– Sell
-29
Closed -$9K – 195
2019
Q4 		$9K Buy
+29
New +$7.98K 0.01% 126
2017
Q4 		$6K Hold
28
– – 0.01% 146
2017
Q3 		$5K Buy
+28
New +$5.33K 0.01% 193

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Corbenic Partners's ELV Position: Q4 2021 in Review

Corbenic Partners sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 11 shares — an estimated $4K sold.

Corbenic Partners first reported a position in ELV in Q3 2017 and held it in 4 quarters. The position peaked at $9K in Q4 2019. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • Corbenic Partners reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • Corbenic Partners sold 11 Elevance Health shares in Q4 2021, an estimated $4K.
  • Corbenic Partners first reported a position in Elevance Health in Q3 2017 and held it in 4 quarters.
  • Corbenic Partners's Elevance Health position peaked at $9K in Q4 2019.
  • 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on Corbenic Partners's 13F filing for Q4 2021, filed 21 Jan 2022.